RA Anderson, N Cheng, NA Bryden, MM Polansky, J … - Diabetes, 1997 - Am Diabetes Assoc Chromium is an essential nutrient involved in normal carbohydrate and lipid metabolism. The
chromium requirement is postulated to increase with increased glucose intolerance and
diabetes. The objective of this study was to test the hypothesis that the elevated intake of ... Cited by 338 - Related articles - BL Direct - All 5 versions
- ►angrylapdog.com RA Anderson - Biological Trace Element Research, 1992 - Springer Chromium functions in maintaining normal glucose tolerance primarily by regulating insulin
action. In the presence of sufficient amounts of chromium, in a biologically active form, much
lower amounts of insulin are required. At the onset of maturity-onset diabetes, there is no ... Cited by 264 - Related articles - BL Direct - All 11 versions
NA Lee, CA Reasner - Diabetes Care, 1994 - Am Diabetes Assoc OBJECTIVE--To investigate the effect of chromium picolinate supplementation on the lipid profile
of the predominantly Hispanic population of non-insulin-dependent diabetes mellitus
(NIDDM) patients in San Antonio, Texas. RESEARCH DESIGN AND METHODS--A ... Cited by 101 - Related articles - BL Direct - All 8 versions
- ►cnfindpark.cn MD Althuis, NE Jordan, EA Ludington, JT … - American Journal of …, 2002 - ajcn.cnfindpark.cn Background: Several authors, mostly on the basis of nonrandomized studies, have suggested
dietary trivalent chromium supplementation as an attractive option for the management of type
2 diabetes and for glycemic control in persons at high risk of type 2 diabetes. Cited by 113 - Related articles - BL Direct - All 8 versions
RA Anderson, NA Bryden, MM Polansky - Journal of the American …, 1997 - Am Coll Nutrition OBJECTIVE: To evaluate the safety of chromium (Cr) as a nutrient supplement. Several recent
studies have reported beneficial effects of supplemental Cr at levels higher than the upper limit
of the suggested intake for Cr. Trivalent Cr is considered relatively nontoxic but some ... Cited by 126 - Related articles - BL Direct - All 7 versions
AS Abraham, BA Brooks, U Eylath - Metabolism: clinical and …, 1992 - ncbi.nlm.nih.gov Seventy-six patients with established atherosclerotic disease were treated daily with either 250
micrograms of chromium orally as chromium chloride or a placebo for a period of 7 to 16 months
(mean, 11.1 months). Serum chromium increased from 2.69 +/- 0.09 to 12.12 +/- 0.77 ... Cited by 120 - Related articles - All 4 versions
BW Morris, S MacNeil, CA Hardisty, S Heller, C … - Journal of trace elements …, 1999 - cat.inist.fr The purpose of this study was to assess chromium handling in non-insulin dependent diabetic
patients(NIDDM) compared to healthy volunteers. Chromium handling was evaluated using fasting
blood and second morning void urine samples from 93 NIDDM patients and 33 healthy ... Cited by 64 - Related articles - BL Direct - All 2 versions
WT Cefalu, AD Bell-Farrow, J Stegner, ZQ … - The Journal of Trace …, 1999 - interscience.wiley.com This study assessed the effect of chromium (Cr) supplementation on insulin sensitivity and body
composition in subjects at high risk for Type 2 diabetes because of family history and
obesity. Twenty-nine subjects (14 men, 15 women) were evaluated in a double-blind, ... Cited by 67 - Related articles - BL Direct
- ►nutrition.org WT Cefalu, ZQ Wang, XH Zhang, LC Baldor, JC … - Journal of …, 2002 - Am Soc Nutrition Human studies suggest that chromium picolinate (CrPic) decreases insulin levels and improves
glucose disposal in obese and type 2 diabetic populations. To evaluate whether CrPic may aid
in treatment of the insulin resistance syndrome, we assessed its effects in ... Cited by 90 - Related articles - BL Direct - All 5 versions
[CITATION] Clinical use of the trace element chromium (III) in the treatment of diabetes mellitus
